Dr. Zablackis is a classically trained Botanist and Marine Biologist having earned two bachelor degrees from the University of California, Berkeley (1979) and a Masters degree from the University of Hawai’i (1985). He completed his PhD in Cell Biology at the University of California, Santa Barbara (1991).
He has spent 30+ years studying polysaccharides in academia an industry, first completing post-doctoral work focused on plant cell wall polysaccharide isolation, purification and structural characterization using a broad range of analytical techniques (HPAEC-PAD, GC, GC-MS, multiple MS platforms and NMR) at the CNRS in France and Complex Carbohydrate Research Center at the University of Georgia (1997); and secondly in the pharmaceutical industry where he joined Bayer Biologics in 1997 as a senior scientist managing the carbohydrate chemistry lab developing and validating analytical methods for recombinant glycoproteins and monoclonal antibodies. He joined Aventis Pasteur in 2000 as an expert in analytical carbohydrate chemistry and method validation. He is currently a Director-Principal Scientist in Global Analytical Sciences at Sanofi Pasteur (the vaccines unit of Sanofi).
Dr. Zablackis serves as a member of the PDA Biopharmaceutical Advisory Board and is the liaison to the PDA Vaccine Interest Group. Additionally, Dr. Zablackis is a member of the USP Expert Committee for Biological Analysis (GCBA) serving as chair of the vaccine subcommittee.